AI Science Tracker
EN

Learned lipid panel distinguishes Alzheimer’s cases in a small clinical cohort

Fudan University; Fourth Military Medical University; Beijing University of Chinese Medicine · 27 Jun 2025 · biology

Discovery

Learned lipid panel distinguishes Alzheimer’s cases in a small clinical cohort

Source check: Source checked. Not independent scientific confirmation.

Finding: Supervised lipid analysis and a support-vector classifier identified a ten-lipid panel distinguishing 26 Alzheimer’s patients from 30 controls in one clinical cohort. The source reports strong internal discrimination, but features were screened using the same cohort before a random split. This is an exploratory clinical association, without external validation, demonstrated diagnostic utility or a causal lipid mechanism.

Technology: PLS-DA feature ranking and support-vector classification of measured plasma lipid profiles

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
The supervised latent model ranked measured lipid features and the SVM combined selected lipids into the represented disease-discrimination panel, beyond univariate lipid measurement alone.
Test and result
The single-center cohort comprised 26 clinically selected Alzheimer’s patients and 30 controls. Supervised PLS-DA importance and statistical filters identified differential lipids; an SVM evaluated a ten-lipid panel with a reported random 70:30 train/test split and cross-validation. The paper reports AUC 0.995 and 98.2% accuracy for the panel, without clearly assigning every headline estimate to an untouched test partition.
Limitation / still unknown
Differential-feature screening precedes the described sample split, so the evaluation does not establish a fully isolated feature-selection pipeline. Small, selected clinical groups and one healthcare system limit generalization. No external validation set, prospective clinical use or causal mechanism was demonstrated. Correlations with cognitive scores are observational and do not establish neuroprotection or treatment targets.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12972415/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Read exact PMC front identity/date, clinical participant/reference criteria, statistical/learned-model Methods, panel-selection and split Results, and stated limitations. Other laboratory procedures and supplements were not independently reviewed. Original online June 27, 2025 distinguished from February 2026 issue. Exact original article front DOI/title and fresh PubMed primary relationship metadata checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse biology discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.